The potential value of lamin B1 as an early diagnostic marker of HCC was demonstrated in the present study, where a statistically significant increase in plasma level among stage 0 HCC patients was observed compared to CLD patients (group II). Here, LMNB1 is linked to hepatocellular carcinoma.